Risk of malignancies in IgG4-related disease

Modern Rheumatology

Volumn 22, Issue 3, 2012, Pages 414-418

  Yamamoto, Motohisa ^a   Takahashi, Hiroki ^a   Tabeya, Tetsuya ^a   Suzuki, Chisako ^a   Naishiro, Yasuyoshi ^a   Ishigami, Keisuke ^a   Yajima, Hidetaka ^a   Shimizu, Yui ^a   Obara, Mikiko ^a   Yamamoto, Hiroyuki ^a   Himi, Tetsuo ^a   Imai, Kohzoh ^b   Shinomura, Yasuhisa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cancer; IgG4; Lymphoma

Indexed keywords

IMMUNOGLOBULIN G4;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CLINICAL FEATURE; COLON CANCER; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOPATHOLOGY; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL;

ADULT; AGED; AUTOIMMUNE DISEASES; FEMALE; FIBROSIS; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; PLASMA CELLS; RISK;

EID: 84861758378     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0520-x     Document Type: Article

References (21)

1. Takahashi H, Yamamoto M, Suzuki C, Naishiro Y, Shinomura Y, Imai K. The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun Rev. 2010;9:591-4.
2. Yamamoto M, Harada S, Ohara M, et al. Clinical and pathological differences between Mikulicz's disease and Sjögren's syndrome. Rheumatology (Oxford). 2005;44:227-34. (Pubitemid 40277409)
3. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-8. (Pubitemid 32204991)
4. Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: Analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68:1310-5.
5. Kamisawa T, Chen PY, Tu Y, et al. Pancreatic cancer with a high serum IgG4 concentration.World J Gastroenterol. 2006;12:6225-8. (Pubitemid 44688178)
6. Fukui T, Mitsuyama T, Takaoka M, et al. Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med. 2008;47:151-5. (Pubitemid 351372627)
7. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T, Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2003: Based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol. 2009;39: 850-8.
8. Ghazale A, Chari S. Is autoimmune pancreatitis a risk factor for pancreatic cancer? Pancreas. 2007;35:376. (Pubitemid 350307384)
9. Loss M, Esposito I, Hedderich DM, et al. Autoimmune pancreatitis complicated by carcinoma of the pancreatobiliary system: A case report and review of the literature. Pancreas. 2011;40:151-4.
10. Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007;34:2088-95. (Pubitemid 350212140)
11. Nguyen VX, De Petris G, Nguyen BD. Usefulness of PET/CT imaging in systemic IgG4-related sclerosing disease. A report of three cases. JOP. 2011;12:297-305.
12. Wilson CB. PET scanning in oncology. Eur J Cancer. 1992;28: 508-10.
13. Masaki Y, Sugai S. Lymphoproliferative disorders in Sjögren's syndrome. Autoimmun Rev. 2004;3:175-82.
14. Zhang W, Feng S, Yan S, Zhao Y, Li M, Sun J, et al. Incidence of malignancy in primary Sjögren's syndrome in Chinese cohort. Rheumatology (Oxford). 2010;49:571-7.
15. Lazarus MN, Robinson D, Mak V, Møller H, Isenberg DA. Incidence of cancer in a cohort of patients with primary Sjögren's syndrome. Rheumatology (Oxford). 2006;45:1012-5. (Pubitemid 44283059)
16. Kauppi M, Pukkala E, Isomäki H. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control. 1997;8:201-4. (Pubitemid 27170375)
17. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: A meta-analysis. Arch Intern Med. 2005;165:2337-44. (Pubitemid 41640845)
18. Takanishi N, Ghazale AH, Smyrk TC, Mandrekar JN, Chari ST. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas. 2009;38:523-6.
19. Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T. IgG4-related disease: Historical overview and pathology of hematological disorders. Pathol Int. 2010;60:247-58.
20. Teng MW, Ngiow SF, von Scheidt B, McLaughlin N, Sparwasser T, Smyth MJ. Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth. Cancer Res. 2010;70:7800-9.
21. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102:1646-53. (Pubitemid 47206688)